Detalhe da pesquisa
1.
Cross-sectional web-based survey among haematologists and gastroenterologists in Japan to identify the key factors for early diagnosis of Gaucher disease.
Intern Med J
; 53(6): 930-938, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499124
2.
Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan.
Orphanet J Rare Dis
; 19(1): 11, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183145
3.
Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: A survey-based study.
Mol Genet Metab Rep
; 36: 100994, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37576570
4.
Safety and efficacy of anagrelide in Japanese post-marketing surveillance, with subgroup analyses on the effect of previous cytoreductive therapies, age, and starting dose.
Int J Hematol
; 116(4): 570-578, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35624199
5.
Validation and reliability of current guidelines for the treatment of essential thrombocythemia under real-world clinical settings in Japan.
Hematology
; 27(1): 157-166, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35068369
6.
Clinical and biological relevance of CREB3L1 in Philadelphia chromosome-negative myeloproliferative neoplasms.
Leuk Res
; 119: 106883, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689957